While overexpression of these three NFκB and AP-1 upregulated genes at the protein level has been well documented for clinically aggressive breast cancers, their prognostic impact at the transcript level had not been previously recognized for ER-positive breast cancer. Here, NFKB1 is linked to breast carcinoma.